Stock KAN KANCERA AB
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Kancera AB

Equities

KAN

SE0015658570

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:54 2024-05-02 am EDT 		5-day change 1st Jan Change
1.426 SEK -2.99% Intraday chart for Kancera AB -4.68% -68.62%
Feb. 23 Kancera AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Feb. 23 Kancera AB Signs A License Agreement with the University of Newcastle CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Kancera Names Successor to Outgoing Chief Medical Officer
MT
Kancera AB Appoints Markus Jerling as Chief Medical Officer
CI
Kancera CEO Moves to Chief Scientific Officer Role; Successor Named
MT
Kancera AB Appoints Thomas Olin as Executive Vice President and Chief Scientific Officer
CI
Kancera AB Appoints Peter Selin as New Chief Executive Officer, Effective from July 1 2023
CI
Kancera reports that the Swedish Medical Products Agency has approved the application to conduct the KANDOVA-study and that Dr. Hanjing Xie has been appointed to Chief Medical Officer
AQ
Kancera AB Appoints Peter Selin as Executive Vice President Corporate Development, Effective May 1, 2022
CI
Kancera AB Provides an Update on the Development of the Company's Pharmaceutical Project and Nominates A New Drug Candidate
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KAN Stock
  4. News Kancera AB
  5. Insiders